SARS-CoV-2 and Cancer-related Products and Services

Cancer patients, who are often immunosuppressed, are particularly vulnerable to complications due to COVID-19. GeneCopoeia has you covered for both cancer and COVID-19 research with industry-leading products and services. You can choose from a wide variety of tools for vaccine evaluation, such as Spike-pseudotyped lentiviruses, receptor stable cell lines, and neutralizing antibody screening services, as well as products for cancer gene function studies, including CRISPR-Cas9, shRNA, miRNA, ORF clones, and cancer biomarker mutation cell lines. For more information, please contact inquiry@gmail.com.

To browse specific products of interest, please follow the tabs below: